Replies to post #121921 on Anavex Life Sciences Corp (AVXL)

[polarbear77]

Yes, that p300 amplitude chart is a show stopper; similar to the June 2017 presentation.

I'd say that the fact that Anavex is STILL making the same positive assertions and claims of efficacy from the 2a extension trial AND still presenting these up-trending cognitive test score charts in TODAY'S presentation speaks volumes to me and is a HUGE TELL about the 15/18/21 month data/scores.

Just my OPINION but it's logical to now assume that the 15/18/21 month results may've maintained near baseline or continued improvement on the charts; otherwise they'd be roundly criticized and scrutinized were they to use old data if new available data was not comparably positive.

IF that last paragraph is accurate, then our odds of success in the coming binary moment MAY have increased significantly. Godspeed, Dr Missling